Donald Kellerman, senior vice president for development and a member of the board at Inspire Pharmaceuticals, is leaving the company.

Inspire (Nasdaq: ISPH) said Kellerman is stepping down as of July 21 to take a position at another pharmaceutical firm. Kellerman has worked at Inspire since 1999.

A former executive at GlaxoSmithKline, Kellerman has been responsible for clinical and regulatory affairs at Inspire.